Folger Nolan Fleming Douglas Capital Management’s CVS Health CVS Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Sell	4,092 -145	-3%	-$12.9K	0.03%	133
2026 Q1	$304K	Sell	4,237 -543	-11%	-$41.8K	0.03%	152
2025 Q4	$379K	Sell	4,780 -492	-9%	-$38.8K	0.04%	130
2025 Q3	$397K	Sell	5,272 -238	-4%	-$16.3K	0.04%	128
2025 Q2	$380K	Buy	5,510 +27	+0.5%	+$1.77K	0.04%	125
2025 Q1	$371K	Sell	5,483 -258	-4%	-$15.4K	0.04%	128
2024 Q4	$258K	Sell	5,741 -1,123	-16%	-$63K	0.03%	148
2024 Q3	$432K	Sell	6,864 -98	-1%	-$5.72K	0.04%	127
2024 Q2	$411K	Sell	6,962 -3,948	-36%	-$247K	0.04%	124
2024 Q1	$870K	Sell	10,910 -199	-2%	-$15.2K	0.09%	87
2023 Q4	$877K	Buy	11,109 +2	+0%	+$142	0.1%	84
2023 Q3	$776K	Buy	11,107 +1	+0%	+$71	0.09%	89
2023 Q2	$768K	Sell	11,106 -9	-0.1%	-$640	0.08%	98
2023 Q1	$826K	Sell	11,115 -698	-6%	-$58.5K	0.1%	93
2022 Q4	$1.1M	Buy	11,813 +2,501	+27%	+$241K	0.13%	83
2022 Q3	$888K	Buy	9,312 +201	+2%	+$19.9K	0.12%	88
2022 Q2	$844K	Hold	9,111	–	–	0.11%	95
2022 Q1	$922K	Buy	9,111 +361	+4%	+$37.9K	0.1%	96
2021 Q4	$903K	Hold	8,750	–	–	0.1%	97
2021 Q3	$743K	Sell	8,750 -70	-0.8%	-$5.86K	0.09%	101
2021 Q2	$736K	Buy	8,820 +200	+2%	+$16.4K	0.09%	101
2021 Q1	$648K	Buy	8,620 +670	+8%	+$48.8K	0.08%	106
2020 Q4	$543K	Hold	7,950	–	–	0.07%	109
2020 Q3	$464K	Hold	7,950	–	–	0.07%	107
2020 Q2	$517K	Hold	7,950	–	–	0.08%	104
2020 Q1	$472K	Hold	7,950	–	–	0.09%	101
2019 Q4	$591K	Sell	7,950 -100	-1%	-$7.02K	0.09%	100
2019 Q3	$508K	Hold	8,050	–	–	0.08%	103
2019 Q2	$439K	Sell	8,050 -400	-5%	-$21.5K	0.07%	118
2019 Q1	$456K	Sell	8,450 -100	-1%	-$6.17K	0.07%	108
2018 Q4	$560K	Buy	8,550 +400	+5%	+$29.9K	0.09%	96
2018 Q3	$642K	Hold	8,150	–	–	0.09%	97
2018 Q2	$524K	Sell	8,150 -272	-3%	-$17.9K	0.08%	105
2018 Q1	$524K	Hold	8,422	–	–	0.08%	106
2017 Q4	$611K	Buy	8,422 +64	+0.8%	+$4.65K	0.09%	100
2017 Q3	$680K	Hold	8,358	–	–	0.1%	93
2017 Q2	$672K	Hold	8,358	–	–	0.1%	92
2017 Q1	$656K	Hold	8,358	–	–	0.1%	96
2016 Q4	$775K	Hold	8,358	–	–	0.13%	91
2016 Q3	$775K	Hold	8,358	–	–	0.13%	91
2016 Q2	$800K	Hold	8,358	–	–	0.14%	87
2016 Q1	$867K	Sell	8,358 -34	-0.4%	-$3.31K	0.16%	83
2015 Q4	$820K	Sell	8,392 -50	-0.6%	-$4.9K	0.15%	87
2015 Q3	$814K	Hold	8,442	–	–	0.17%	85
2015 Q2	$885K	Hold	8,442	–	–	0.16%	82
2015 Q1	$871K	Sell	8,442 -200	-2%	-$20.2K	0.15%	86
2014 Q4	$832K	Hold	8,642	–	–	0.14%	85
2014 Q3	$688K	Hold	8,642	–	–	0.12%	91
2014 Q2	$651K	Sell	8,642 -94	-1%	-$7.1K	0.12%	95
2014 Q1	$654K	Hold	8,736	–	–	0.13%	90
2013 Q4	$625K	Buy	8,736 +1	+0%	+$64	0.11%	92
2013 Q3	$496K	Buy	8,735 +600	+7%	+$35.8K	0.1%	95
2013 Q2	$465K	Buy	+8,135	New	+$471K	0.1%	93

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's CVS Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its CVS Health (CVS) stake by 3.4% in Q2 2026, selling an estimated $12.9K and leaving 4,092 shares worth $423K. The position accounts for 0.03% of the portfolio, ranked #133.

Folger Nolan Fleming Douglas Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.1M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Folger Nolan Fleming Douglas Capital Management held 4,092 shares of CVS Health worth $423K as of Q2 2026.
Folger Nolan Fleming Douglas Capital Management sold 145 CVS Health shares in Q2 2026, an estimated $12.9K.
CVS Health made up 0.03% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #133 holding.
Folger Nolan Fleming Douglas Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
Folger Nolan Fleming Douglas Capital Management's CVS Health position peaked at $1.1M in Q4 2022.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.